Allergology International (Jan 2020)

Mesenchymal stem cells in allergic diseases: Current status

  • He Li,
  • Yunzhe Tian,
  • Lihui Xie,
  • Xiuxing Liu,
  • Zhaohao Huang,
  • Wenru Su

Journal volume & issue
Vol. 69, no. 1
pp. 35 – 45

Abstract

Read online

Allergic diseases, which include asthma, allergic skin diseases, allergic rhinitis and allergic conjunctivitis, have already garnered worldwide public health attention over recent decades. Mesenchymal stem cells (MSCs) have gradually emerged as a potential method for treating allergic diseases due to their immunosuppressive characteristics, tissue repair ability and secretion of various biological factors. This potential of MSC-based therapy has been confirmed in clinical and preclinical studies, which report the therapeutic benefits of MSCs for various allergic diseases and explore the antiallergic mechanisms. In this review, we focus on the discoveries and biological mechanisms of MSCs as a therapeutic tool in allergic diseases. We discuss the challenges of conducting MSC studies as well as future directions. Keywords: Allergic disease, Asthma, Exosomes, Immunomodulation, Mesenchymal stem cells